PUNE, India, March 3, 2016 /PRNewswire/ --
The cellular and gene therapy industry has seen quite a lot of developments in the last decade, majorly driven by the constant search for cures of diseases rather than their mitigation. Commercially, there have been only a few products mostly due to the economic, technical, and regulatory challenges faced for successful adoption. Laboratories play a pivotal role in clinical development and commercialization of products, and hence, should understand what industries need for effective development of products on a commercial scale. The key for overall success of the entire industry is constant and effective interaction between professionals working in cell processing, cell biologists involved in product development and bioprocess engineers that are key people involved in scalability and manufacturing processes.
(Logo: http://photos.prnewswire.com/prnh/20160303/792302 )
With an aim to bring together these professionals together, MarketsandMarkets Conferences is organizing the Bioprocessing of Advanced Cellular Therapies Congress in London, UK on 2nd and 3rd June 2016. The aim of the meeting is to look at the latest developments in the cellular and gene therapy industry and effectively overcome current challenges. Key sessions at the congress will include case studies, presentations and panel discussions on upstream process development for gene therapies, upstream process development for cell-based therapies, downstream processing considerations, insights into business development and reimbursement and regulatory perspectives.
Speaking at the congress are experts representing organizations such as Centre for Commercialization of Regenerative Medicine, Oxford BioMedica, INFARMED, Généthon, Aston University, Cell Therapy Catapult, Novartis Farma - Produtos Farmaceuticos S.A., University College of London, National Institute of Standards and Technology, GlaxoSmithKline, Audentes Therapeutics and Kiadis Pharma.
Steve Oh - Director Stem Cell Bioprocessing; BIP Programme Director & Senior Principal Scientist, Stem Cell Group at the Bioprocessing Technology Institute, Singapore is one of the key speakers at the congress. Talking about the congress and its key takeaway, he said, "Bioprocessing should be thought of as a first thing when you think about making cell therapies, not the last one. The congress will play a big role in updating the attendees with the fast moving bioprocessing field of cell therapies."
The congress will serve as a great opportunity to facilitate links between experts in the field to encourage collaborations, devise new strategies and generally working towards more cost - effective solutions.
About MarketsandMarkets Conferences:
MarketsandMarkets Conferences (MnM Conferences) produces global summits, congresses and conferences bringing together key industry experts from academia and industry sharing and exchanging ideas and latest research through cutting edge conference programs and interactive panel and round table discussions.
Media Contact:
Ajay Nimbalkar
Tel: + 91 20 6708 0270
Email: [email protected]
Twitter: https://twitter.com/mnmconferences
LinkedIn: https://www.linkedin.com/company/mnm-conferences
Share this article